GB9306460D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB9306460D0 GB9306460D0 GB939306460A GB9306460A GB9306460D0 GB 9306460 D0 GB9306460 D0 GB 9306460D0 GB 939306460 A GB939306460 A GB 939306460A GB 9306460 A GB9306460 A GB 9306460A GB 9306460 D0 GB9306460 D0 GB 9306460D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Nutrition Science (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939306460A GB9306460D0 (en) | 1993-03-29 | 1993-03-29 | Novel compounds |
| EP94912514A EP0691973A1 (fr) | 1993-03-29 | 1994-03-22 | DERIVES THIENO-INDOLIQUES UTILISES COMME ANTAGONISTES DE 5HT2c ET DE 5HT2b |
| JP6521640A JPH08508275A (ja) | 1993-03-29 | 1994-03-22 | ５ＨＴ▲下２▼▲下ｃ▼および５ＨＴ▲下２▼▲下ｂ▼アンタゴニストとしてのチエノ−インドール誘導体 |
| PCT/EP1994/000917 WO1994022871A1 (fr) | 1993-03-29 | 1994-03-22 | DERIVES THIENO-INDOLIQUES UTILISES COMME ANTAGONISTES DE 5HT2c ET DE 5HT2b |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939306460A GB9306460D0 (en) | 1993-03-29 | 1993-03-29 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9306460D0 true GB9306460D0 (en) | 1993-05-19 |
Family
ID=10732915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB939306460A Pending GB9306460D0 (en) | 1993-03-29 | 1993-03-29 | Novel compounds |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0691973A1 (fr) |
| JP (1) | JPH08508275A (fr) |
| GB (1) | GB9306460D0 (fr) |
| WO (1) | WO1994022871A1 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0757687A1 (fr) * | 1994-04-23 | 1997-02-12 | Smithkline Beecham Plc | Derives tricycliques antagonistes de 5ht2c et de 5ht2b |
| GB9420521D0 (en) * | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| EP0807104A2 (fr) * | 1995-02-02 | 1997-11-19 | Smithkline Beecham Plc | Composes heterocycliques possedant une activite antagoniste vis-a-vis du recepteur de 5ht 2c? |
| JPH10513442A (ja) * | 1995-02-02 | 1998-12-22 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５−ｈｔレセプターアンタゴニストとしてのインドール誘導体 |
| EP0831835B1 (fr) * | 1995-06-01 | 2002-10-30 | Eli Lilly And Company | Traitement de l'anorexie |
| GB9607219D0 (en) * | 1996-04-04 | 1996-06-12 | Smithkline Beecham Plc | Novel compounds |
| GB9724372D0 (en) * | 1997-11-18 | 1998-01-14 | Smithkline Beecham Plc | Novel compounds |
| FR2807754A1 (fr) * | 2000-04-13 | 2001-10-19 | Adir | Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US7612078B2 (en) | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
| ATE511511T1 (de) | 2003-03-31 | 2011-06-15 | Trovis Pharmaceuticals Llc | Neue piperidinylaminothienoä2,3-dü pyrimidinverbindungen |
| US7488736B2 (en) | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| US7598265B2 (en) | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
| US7407966B2 (en) | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| US7576211B2 (en) | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
| WO2010065743A2 (fr) | 2008-12-03 | 2010-06-10 | Nanotherapeutics, Inc. | Composés bicycliques et leurs procédés de fabrication et d'utilisation |
| KR20140143804A (ko) * | 2012-03-21 | 2014-12-17 | 메르크 파텐트 게엠베하 | 벤조［１，２―ｂ；４，５―ｂ′］디티오펜―４，８―디카르복실산 또는 이의 ２，３―디히드로 유도체의 제조 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0550507A1 (fr) * | 1990-09-13 | 1993-07-14 | Beecham Group p.l.c. | Urees d'indole utilisees comme antagonistes de recepteur de 5-ht |
| EP0630373A1 (fr) * | 1992-03-12 | 1994-12-28 | Smithkline Beecham Plc | Derives d'indole utilises comme antagonistes de 5ht 1c? |
| WO1994004533A1 (fr) * | 1992-08-20 | 1994-03-03 | Smithkline Beecham Plc | DERIVES D'INDOLE CONDENSES UTILISES COMME ANTAGONISTES DES RECEPTEURS 5HT2C et 5HT¿2B? |
-
1993
- 1993-03-29 GB GB939306460A patent/GB9306460D0/en active Pending
-
1994
- 1994-03-22 EP EP94912514A patent/EP0691973A1/fr not_active Withdrawn
- 1994-03-22 WO PCT/EP1994/000917 patent/WO1994022871A1/fr not_active Application Discontinuation
- 1994-03-22 JP JP6521640A patent/JPH08508275A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0691973A1 (fr) | 1996-01-17 |
| JPH08508275A (ja) | 1996-09-03 |
| WO1994022871A1 (fr) | 1994-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9311661D0 (en) | Novel compounds | |
| GB9302275D0 (en) | Novel compounds | |
| AP9400653A0 (en) | Novel compounds | |
| GB9315148D0 (en) | Novel compounds | |
| GB9306460D0 (en) | Novel compounds | |
| GB9306183D0 (en) | Novel compounds | |
| GB9311644D0 (en) | Novel compounds | |
| GB9308963D0 (en) | Novel compounds | |
| GB9310485D0 (en) | Novel compounds | |
| GB9303825D0 (en) | Novel compounds | |
| GB9306182D0 (en) | Novel compounds | |
| GB9306235D0 (en) | Novel compounds | |
| GB9308178D0 (en) | Novel compounds | |
| GB9307694D0 (en) | Novel compounds | |
| GB9311027D0 (en) | Novel compounds | |
| GB9312602D0 (en) | Novel compounds | |
| GB9309835D0 (en) | Novel compounds | |
| GB9309182D0 (en) | Novel compounds | |
| GB9309181D0 (en) | Novel compounds | |
| GB9309180D0 (en) | Novel compounds | |
| GB9309178D0 (en) | Novel compounds | |
| GB9308969D0 (en) | Novel compounds | |
| GB9309838D0 (en) | Novel compounds | |
| GB9310687D0 (en) | Novel compounds | |
| GB9307477D0 (en) | Novel compounds |